-
UPDATE: RBC Capital Starts Catalent (CTLT) at Outperform
-
Catalent (CTLT) PT Raised to $45 at RBC Capital
-
Catalent (CTLT) PT Lowered to $44 at RBC Capital
-
Catalent (CTLT) Prices 9.94M Share Common Offering at $40.24/Sh
-
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
-
Catalent (CTLT) to Offer $400M in Common Stock
-
Catalent, Inc. Announces Public Offering of Common Stock
-
Catalent, Inc. to Present at Two Upcoming Investor Conferences
-
RBC Capital Starts Catalent (CTLT) at Outperform
-
Catalent (CTLT) Prices 6.395M Common Share Offering at $39.10/Sh
-
Catalent, Inc. Announces Pricing of Public Offering of Common Stock to Fund Part of its Acquisition of Cook Pharmica
-
Catalent (CTLT) Launches $250M Common Stock Offering
-
Catalent, Inc. Announces Public Offering of Common Stock to Fund Part of its Acquisition of Cook Pharmica
-
Catalent (CTLT) to Acquire Cook Pharmica for $950M
-
Catalent to Acquire Cook Pharmica for $950 Million
-
Notable Mergers and Acquisitions 11/28: (EW) (CDEV) (VRSK) (CTLT)
-
Catalent (CTLT) Announces Acquisition of OTC Softgel Maker Accucaps Industries
-
Catalent Acquires Accucaps to Expand Softgel Development and Manufacturing Capabilities and Capacity
-
Notable Analyst Rating Changes 6/21: (APLP) (DKL) (HP) Upgraded; (USAC) (WMAR) (CPS) Downgraded

